BR9809090A - Método e composição para o tratamento da apnéia do sono - Google Patents

Método e composição para o tratamento da apnéia do sono

Info

Publication number
BR9809090A
BR9809090A BR9809090-9A BR9809090A BR9809090A BR 9809090 A BR9809090 A BR 9809090A BR 9809090 A BR9809090 A BR 9809090A BR 9809090 A BR9809090 A BR 9809090A
Authority
BR
Brazil
Prior art keywords
apnea
treatment
composition
sleep
sleep apnea
Prior art date
Application number
BR9809090-9A
Other languages
English (en)
Inventor
Keith C Meyer
M Safwan Badr
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of BR9809090A publication Critical patent/BR9809090A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

"MéTODO E COMPOSIçãO PARA O TRATAMENTO DA APNéIA DO SONO". Aplicação de tensoativo de pulmão natural ou sintético à região farínge posterior antes de um período de sono reduz significativamente episódios de perturbações do sono resultando em apnéia ou hipopnéia. A presente invenção proporciona tensoativo em um recipiente aplicador conveniente, fácil de ser usado e estocado. Os incidentes de dessaturação de oxigênio são reduzidos, diminuindo assim os riscos de patologias associadas à apnéia.
BR9809090-9A 1997-04-16 1998-04-16 Método e composição para o tratamento da apnéia do sono BR9809090A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/834,369 US5958902A (en) 1997-04-16 1997-04-16 Method and composition for treating sleep apnea
PCT/US1998/007735 WO1998046245A1 (en) 1997-04-16 1998-04-16 Method and composition for treating sleep apnea

Publications (1)

Publication Number Publication Date
BR9809090A true BR9809090A (pt) 2002-12-03

Family

ID=25266775

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809090-9A BR9809090A (pt) 1997-04-16 1998-04-16 Método e composição para o tratamento da apnéia do sono

Country Status (23)

Country Link
US (3) US5958902A (pt)
EP (1) EP1009411B1 (pt)
JP (1) JP2001507364A (pt)
KR (1) KR100381643B1 (pt)
CN (1) CN1252727A (pt)
AR (1) AR012221A1 (pt)
AT (1) ATE298241T1 (pt)
AU (1) AU722866B2 (pt)
BG (1) BG103800A (pt)
BR (1) BR9809090A (pt)
CA (1) CA2285574C (pt)
CO (1) CO4940399A1 (pt)
DE (1) DE69830660T2 (pt)
HU (1) HUP0002645A3 (pt)
ID (1) ID29298A (pt)
IL (2) IL132133A0 (pt)
NO (1) NO994613L (pt)
NZ (1) NZ337969A (pt)
PL (1) PL336326A1 (pt)
SK (1) SK143199A3 (pt)
TR (1) TR199902577T2 (pt)
TW (1) TWI221771B (pt)
WO (1) WO1998046245A1 (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6641542B2 (en) * 2001-04-30 2003-11-04 Medtronic, Inc. Method and apparatus to detect and treat sleep respiratory events
US20060057227A1 (en) * 2002-02-15 2006-03-16 Fisher Jeffrey J Throat spray
JP4384503B2 (ja) 2002-03-20 2009-12-16 アルカーメス，インコーポレイテッド レボドパの肺送達
US7992566B2 (en) 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US7647931B2 (en) 2002-12-30 2010-01-19 Quiescence Medical, Inc. Stent for maintaining patency of a body region
US7381222B2 (en) 2002-12-30 2008-06-03 Quiescence Medical, Inc. Stent for maintaining patency of a body region
WO2007005672A2 (en) * 2005-06-30 2007-01-11 The Scripps Research Institute Treatment and prevention of respiratory diseases and conditions
JP2007190277A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器および呼吸訓練プログラム
JP2007190275A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器
JP2007190278A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器
CA2641821C (en) * 2006-02-16 2017-10-10 Imthera Medical, Inc. An rfid-based apparatus, system, and method for therapeutic treatment of a patient
US7734350B2 (en) * 2006-06-14 2010-06-08 Zmed Technologies, Inc. Respiration apparatus
WO2007147046A2 (en) * 2006-06-14 2007-12-21 Zmed Technologies, Inc. Respiration stimulation
EP2037850A2 (en) 2006-07-06 2009-03-25 Quiescence Medical Inc Apparatus and methods for treating sleep apnea
CA2697826A1 (en) * 2007-10-09 2009-04-16 Imthera Medical, Inc. System and method for neural stimulation
JP5570996B2 (ja) 2007-12-14 2014-08-13 エアロデザインズ インコーポレイテッド エアロゾル化可能な食料品の送達
EP2349139B1 (en) 2008-10-09 2017-05-31 Imthera Medical, Inc. Stimulation of a hypoglossal nerve for controlling the position of a patient's tongue
KR20120101650A (ko) 2009-11-10 2012-09-14 임테라 메디칼, 인코포레이티드 환자 혀의 위치를 제어하기 위한 혀밑 신경 자극용 시스템
US9844336B2 (en) 2010-08-26 2017-12-19 Ben Gurion University Of The Negev Research And Development Authority Apparatus and method for diagnosing obstructive sleep apnea
US9265649B2 (en) 2010-12-13 2016-02-23 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US20120220531A1 (en) 2011-02-04 2012-08-30 Cincinnati Children's Hospital Medical Center Surfactant protein d for the treatment of disorders associated with lung injury
US10265013B2 (en) 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
US10265014B2 (en) 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
CN105053192A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种椰香补肾豆渣发酵乳及其制备方法
CN105053197A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种温中补血豆渣发酵乳及其制备方法
CN105053195A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种去火薄荷味豆渣发酵乳及其制备方法
CN104982527A (zh) * 2015-07-30 2015-10-21 安徽人人福豆业有限公司 一种安神豆渣发酵乳及其制备方法
CN105123926A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种疏肝理气豆渣发酵乳及其制备方法
CN105104535A (zh) * 2015-07-30 2015-12-02 安徽人人福豆业有限公司 一种养颜豆渣发酵乳及其制备方法
CN105123927A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种芦荟健胃豆渣发酵乳及其制备方法
CN105053194A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种清热通络豆渣发酵乳及其制备方法
CN105123928A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种润肠豆渣发酵乳及其制备方法
CN105010535A (zh) * 2015-07-30 2015-11-04 安徽人人福豆业有限公司 一种银耳豆渣发酵乳及其制备方法
CN104996566A (zh) * 2015-07-30 2015-10-28 安徽人人福豆业有限公司 一种清肺酒香豆渣发酵乳及其制备方法
CN105053191A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种消食木瓜豆渣发酵乳及其制备方法
CN105053196A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种风味草莓豆渣发酵乳及其制备方法
WO2019018338A1 (en) 2017-07-17 2019-01-24 Northriver Pharm, LLC NASAL COMPOSITION COMPRISING A MUCOADHESIVE POLYMER
CN111568853B (zh) * 2020-04-30 2023-07-28 杭州濡湜生物科技有限公司 一种新型肺部智能释药系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2520234A1 (fr) * 1982-01-28 1983-07-29 Gros Pierre Composition destinee a la prevention du ronflement
US4826821A (en) * 1985-06-26 1989-05-02 The Regents Of The University Of California Lung surfactant compositions
EP0273916A4 (en) * 1986-05-06 1989-11-30 Childrens Hosp Medical Center LUNG HYDROPHOBES, PROTEIN ASSOCIATED TO A SURFACE ACTIVE MEDIUM OF 6000 DALTON MOLECULAR WEIGHT AND MULTIMEREOUS ITEMS.
JPS63208524A (ja) * 1987-02-25 1988-08-30 Nippon Oil & Fats Co Ltd 睡眠リズム改善剤
US5238920A (en) * 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
EP0458167B1 (en) * 1990-05-21 1997-04-23 Abbott Laboratories Fatty acid-pulmonary surfactant conjugates
ATE231522T1 (de) * 1992-04-10 2003-02-15 Abbott Lab Fragmente eines oberflächenaktiven lungenproteins
US5569679A (en) * 1994-12-30 1996-10-29 Russell A. Krueger Pharmaceuticals, Inc. Pharmacologic management of snoring
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US5925334A (en) * 1997-08-27 1999-07-20 Rubin; Bruce K. Use of surface active agents to promote mucus clearance

Also Published As

Publication number Publication date
US5958902A (en) 1999-09-28
HUP0002645A2 (hu) 2001-06-28
CN1252727A (zh) 2000-05-10
SK143199A3 (en) 2001-01-18
KR20010006384A (ko) 2001-01-26
NO994613L (no) 1999-10-28
IL132133A0 (en) 2001-03-19
US20020099033A1 (en) 2002-07-25
BG103800A (en) 2000-03-31
HK1026141A1 (en) 2000-12-08
IL132133A (en) 2008-12-29
TR199902577T2 (xx) 2000-02-21
ID29298A (id) 2001-08-16
EP1009411A4 (en) 2002-10-09
EP1009411A1 (en) 2000-06-21
TWI221771B (en) 2004-10-11
PL336326A1 (en) 2000-06-19
ATE298241T1 (de) 2005-07-15
AU722866B2 (en) 2000-08-10
CA2285574C (en) 2007-11-13
NZ337969A (en) 2001-12-21
JP2001507364A (ja) 2001-06-05
HUP0002645A3 (en) 2002-12-28
EP1009411B1 (en) 2005-06-22
NO994613D0 (no) 1999-09-23
AR012221A1 (es) 2000-09-27
DE69830660T2 (de) 2006-05-04
KR100381643B1 (ko) 2003-04-26
US6329352B1 (en) 2001-12-11
WO1998046245A1 (en) 1998-10-22
CO4940399A1 (es) 2000-07-24
DE69830660D1 (de) 2005-07-28
CA2285574A1 (en) 1998-10-22
AU6975598A (en) 1998-11-11

Similar Documents

Publication Publication Date Title
BR9809090A (pt) Método e composição para o tratamento da apnéia do sono
HU9503702D0 (en) Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin
MXPA02009794A (es) Composicion para promover el sueno-.
ES2170223T3 (es) Composicion farmaceutica que contiene hidratos de carbonato de lantano seleccionados.
GB0123381D0 (en) Factor
AU2002357676A1 (en) Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation
ZA9432B (en) Use of anticonvulsants in the treatment of Parkinson's Disease and Parkinsonian Syndromes
BR0008926A (pt) Utilização de um extrato de uva, rico ouenriquecido em polifenóis e processo detratamento cosmético do corpo humano
IL152554A0 (en) PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A FACTOR XIII
SE8801732L (sv) Ny komposition
PT1261333E (pt) Utilizacao de topiramato para o tratamento e diagnostico de transtorno do sono relacionado com a respiracao e meios para realizar o metodo e o diagnostico
ZA981780B (en) The use of levobupivacaine in paediatric surgery
BR0013353A (pt) Combinação de substância ativa com clonidina
IL131084A0 (en) The use of levobupivacaine in facial surgery
DE68916197D1 (de) Zusammensetzung zur in-vivo bzw. in-vitro steigerung des melaningehaltes der melanocyten und deren in-vitro verwendung.
DK1338270T3 (da) Anvendelse af en dihydrochalkon-rig phenolfraktion i en kosmetisk behandling
TR200001293T2 (tr) Uykuda solunum durmasını tedavi etmek için mirtazapin kullanımı
UA72927C2 (uk) Композиція для лікування печінково-клітинного раку, що містить доцетаксель
IL97054A0 (en) Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas
DE69331008D1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
DE59811643D1 (de) Haarbehandlungsmittel
AU2003223528A8 (en) Treatment for type 1 diabetes before and after expression of predisposition markers.
AU125807S (en) Sleepmask
UA10995C2 (uk) Препарат "hейтрам" для лікуваhhя hеоhатальhих діарей у телят
GR1003762B (el) Σαπουνι με φυσικο γαλα και βασιλικο πολτο.

Legal Events

Date Code Title Description
B09B Patent application refused [chapter 9.2 patent gazette]